Funded Project Details - FY2021
|Title:|| A Novel Small Molecule Inhibitor of Sclerostin to Improve Surgical Spine Fusions In Vivo|
Steven M Presciutti
|Congressional District Code:
||Biomedical Laboratory R&D
|| July 2017 -
|FY 2021 Funding Amount:
|Total Award Amount
View full abstract and other project information on NIH RePORTER
Go To NIH RePORTER
Spinal arthrodesis procedures are commonly performed in our veterans for a wide range of pathology. Despite state-of-the-art surgical procedures, fusion failure rates still range from 10-40%. This is important, as failure to fuse is often associated with continued pain, worse outcomes, increased medication requirements, and possibly the cost of additional surgeries. Given the individual shortcomings of the currently available bone graft options, there is a clear clinical need for additional stra...
Questions about the R&D website? Email the Web Team
Any health information on this website is strictly for informational purposes and is not intended as medical advice. It should not be used to diagnose or treat any condition.